Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adolescents aged 13–17 or young adults aged 18–21 years old
- People who have been diagnosed with Type 1 diabetes for at least one year
- People who have access to a smartphone
- People who have an active My Health at Vanderbilt (MHAV) patient portal account
- People who can read, speak, and understand English
- People who have an upcoming appointment with a nurse practitioner at the VUMC Eskind Clinic within 7 months of first being contacted about the trial
Who may not be able to join:
- People who have been diagnosed with Type 2 diabetes (rather than Type 1)
- People who have a physical, cognitive, sensory, or emotional condition that would make it difficult to participate — for example, difficulty seeing or using a phone, hearing audio stories, or answering questions
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Shelagh A Mulvaney, PhD, Vanderbilt University
Phone: 615-343-6075
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Glycemic Control (HbA1c)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.